Synergizing pharmacometrics and pharmacovigilance for medication error management: the case of secukinumab-Reference-Cited by-同舟云学术

Synergizing pharmacometrics and pharmacovigilance for medication error management: the case of secukinumab

Published:2024-06-01 Issue:9 Volume:80 Page:1339-1341
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Fromage Yeleen,Sayadi Hamza,Monchaud Caroline,Labriffe Marc,Scaramuzzino Léa,Géniaux Hélène,Woillard Jean-Baptiste^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00228-024-03705-6.pdf

Reference4 articles.

1. cosentyx-epar-product-information_en.pdf [cité 9 déc 2023] Disponible sur. https://www.ema.europa.eu/en/documents/product-information/cosentyx-epar-product-information_en.pdf

2. Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG et al (2023) Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials. Lancet 401(10378):747–61

3. Bruin G, Loesche C, Nyirady J, Sander O (2017) Population pharmacokinetic modeling of secukinumab in patients with moderate to severe psoriasis. J Clin Pharmacol 57(7):876–885

4. Elmokadem A, Riggs MM, Baron KT (2019) Quantitative systems pharmacology and physiologically-based pharmacokinetic modeling with mrgsolve: a hands-on tutorial. CPT Pharmacometrics Syst Pharmacol 8(12):883–893

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infliximab/unspecified antibacterials;Reactions Weekly;2024-08-31